| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.8 | 0.002 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.32 | 0.3 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.3 | 0.3 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.27 | 1e-14 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.26 | 3e-11 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.25 | 3e-06 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.25 | 4e-13 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.24 | 9e-06 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.23 | 1e-09 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.22 | 1e-09 |